Conference Coverage

VIDEO: BMI helps predict bone fragility in obese patients


 

REPORTING FROM AACE 2018

– An index that takes into account the ratio between body mass index (BMI) and bone mineral density (BMD) correlated well with trabecular bone scores, a newer assessment of bone fragility. The index may help predict risk for fragility fractures in individuals with obesity when trabecular bone scores are not available.

“Obesity is traditionally thought to be protective against bone fractures,” said Mikiko Watanabe, MD, an endocrinologist at Sapienza University of Rome. “But recent evidence suggests that this is not entirely true, especially in morbidly obese patients.”

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.


Lumbar spine BMD alone may not accurately capture bone fragility in patients with obesity, said Dr. Watanabe in an interview at the annual meeting of the American Association of Clinical Endocrinologists.

Adding the trabecular bone score (TBS) to BMD gives additional information about bone microarchitecture, refining risk assessment for fragility fractures. This newer technology, however, may not be readily available and may be associated with extra cost.

Accordingly, said Dr. Watanabe, the study’s senior investigator, Sapienza University’s Carla Lubrano, MD, had the idea to index bone density to BMI, and then see how well the ratio correlated to TBS; obesity is known to be associated with lower TBS scores, indicating increased bone fragility.

Living in Italy, with relatively fewer medical resources available, “We were trying to find some readily available index that could predict the risk of fracture as well as the indexes that are around right now,” said Dr. Watanabe.

“We did find some very interesting data in our population of over 2,000 obese patients living in Rome,” she said. “We do confirm something from the literature, where BMD tends to go high with increasing BMI.” Further, the relatively weak correlation between TBS and BMI was confirmed in the investigators’ work (r = 0.3).

Pages

Recommended Reading

Preferred osteoporosis treatment order with teriparatide, denosumab reaffirmed
MDedge Rheumatology
Teriparatide reduces fractures over risedronate in all subgroups with osteoporosis
MDedge Rheumatology
Romosozumab reduces fracture risk out to 36 months, with no signs of cardiovascular problems
MDedge Rheumatology
ACP osteoporosis treatment guideline debated
MDedge Rheumatology
Gap in osteoporosis diagnosis and treatment stirs concern
MDedge Rheumatology
PBC linked to low BMD, increased risk of osteoporosis
MDedge Rheumatology
VIDEO: Dr. Andrew Kaunitz’s top lessons from NAMS 2017
MDedge Rheumatology
Use of opioids, SSRIs linked to increased fracture risk in RA
MDedge Rheumatology
European Commission expands denosumab indication
MDedge Rheumatology
Spine fracture risk may be increased in IBD patients
MDedge Rheumatology